ArticleCureus2026
Impact of Home-Based Antineoplastic Treatment Administration on Portuguese Patients: A Real-World Study of the ONConsigo Project.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCancer places a substantial burden on patients and healthcare systems, highlighting the need for patient-centered care models. Home-based oncology care has emerged as a strategy to improve quality of life (QoL). The ONConsigo project, implemented in Portugal in June 2023, delivers systemic cancer treatment at home.
methodsThis observational cohort study included patients enrolled in the ONConsigo program. QoL was assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) and the Personal Well-Being Index (PWI) at baseline and 2-6 months after treatment initiation. Paired comparisons were performed using the Wilcoxon signed-rank test, with p-values adjusted for multiple comparisons using the Benjamini-Hochberg false discovery rate (FDR) procedure. Statistical significance was set at p<0.05.
resultsSixty-two patients were included (median age: 82 years; 51.6% male). Most of them had prostate (50%) or breast cancer (48.4%), and 61.3% were treated with palliative intent. Significant improvements were observed in treatment-related interference with family life, social life, and financial difficulties (all FDR-adjusted p=0.01). No significant changes were observed in the remaining questionnaire items after correction for multiple comparisons.
conclusionsHome-based oncology care was associated with improvements in perceived global health status and in family, social, and financial dimensions of QoL, reducing treatment-related interference in daily life and decreasing financial burden. These findings support domiciliary antineoplastic therapy as a feasible patient-centered care model that warrants further evaluation in prospective controlled studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.